SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹30 Cr | ₹17 Cr | ₹13 Cr | ₹3.31 Cr | ₹3.88 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHREE GANESH REMEDIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹3.31 Cr |
Mar2020 | ₹3.88 Cr |
How is Cash Flow from Operating Activities of SHREE GANESH REMEDIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | 78.09 | |
Mar2023 | ₹17 Cr | 27.43 | |
Mar2022 | ₹13 Cr | 305.10 | |
Mar2021 | ₹3.31 Cr | -14.62 | |
Mar2020 | ₹3.88 Cr | - |
Compare Cash Flow from Operating Activities of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹869.5 Cr | -4.9% | -2.9% | 1.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,098.0 Cr | 0.4% | -2.6% | 36% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,194.0 Cr | -0% | 3% | 54.9% | Stock Analytics | |
CIPLA | ₹116,773.0 Cr | -0.2% | -4% | 10.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,646.0 Cr | -2.6% | -1.8% | 13.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,125.0 Cr | -0.6% | 1% | 40.8% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -4.9% |
-2.9% |
1.9% |
SENSEX | 1% |
-3.9% |
5.1% |
You may also like the below Video Courses